In 2022, U.S. business logistics costs hit $2.3 trillion, representing the highest percentage (9.1%) of the national gross domestic product ever, according to the 2023 State of Logistics report. The ...
Introduction: Proteins and amino acids, as vital biomolecules, are not only part of key metabolic pathways in the body but are also essential for tissue repair, enzyme function, and hormone regulation ...
Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, ...
Millions more U.S. households had difficulty securing enough food last year compared to 2021, including 1 million more households with children, a bleak report from the U.S. Agriculture Department ...
WASHINGTON, Sept 28 (Reuters) - U.S. economic activity was either even weaker or not as strong as previously estimated in each of the first quarters of 2020, 2021 and 2022 amid downgrades mostly to ...
New York, June 01, 2023 — With the influx of consumer generative AI programs like Google’s Bard and OpenAI’s ChatGPT, the generative AI market is poised to explode, growing to $1.3 trillion over the ...
Last year the FDA’s Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. This is a drop from the highs of the past 5 years, and brings the rolling 5-year average down to 49 drugs ...
Bugatti is nothing if not enterprising. With clever and careful manipulation of its one platform and engine it has turned the Chiron into the world’s fastest car (Super Sport 300+), an unlikely ...
The number of international migrants grew to 281 million in 2020, meaning that 3.6% of the world’s people lived outside their country of birth that year, according to the United Nations’ International ...
Immunotherapy has emerged as a breakthrough strategy in cancer treatment. mRNA vaccines are an attractive and powerful immunotherapeutic platform against cancer because of their high potency, ...
G protein–coupled receptor, family C, group 5, member D (GPRC5D) is an orphan receptor expressed in malignant plasma cells. Talquetamab, a bispecific antibody against CD3 and GPRC5D, redirects T cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback